Prestwick Pharma Raises $20 Million

Prestwick Pharmaceuticals Inc., a Washington, D.C.-based drug company focused on CNS disorders, has raised $20 million in new VC funding, according to VentureWire. Return backers include Atlas Venture, Pequot Ventures, Scale Venture Partners, Sofinnova Ventures, Vivo Ventures and Warburg Pincus. The company now has raised around $140 million in total VC funding since 2002. www.prestwickpharma.com